Investigators Publish Three-Year Outcome Analysis From PlanB Study Using Oncotype DX | GenomeWeb

A correction has been made to the name of the group leading the PlanB study.

NEW YORK (GenomeWeb) – European investigators have published new outcomes results from the large PlanB study in which Genomic Health's Oncotype DX breast cancer test has been used to guide treatment for women with node-negative and node-positive breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.